Your browser doesn't support javascript.
loading
Defining the molecular evolution of extrauterine high grade serous carcinoma.
Beirne, James P; McArt, Darragh G; Roddy, Aideen; McDermott, Clara; Ferris, Jennifer; Buckley, Niamh E; Coulter, Paula; McCabe, Nuala; Eddie, Sharon L; Dunne, Philip D; O'Reilly, Paul; Gilmore, Alan; Feeney, Laura; Ewing, David Lyons; Drapkin, Ronny I; Salto-Tellez, Manuel; Kennedy, Richard D; Harley, Ian J G; McCluggage, W Glenn; Mullan, Paul B.
Afiliación
  • Beirne JP; Ovarian Cancer Research Programme, Centre for Cancer Research and Cell Biology, Queen's University, Belfast, United Kingdom of Great Britain and Northern Ireland; Northern Ireland Centre for Gynaecological Cancer, Belfast Health and Social Care Trust, Belfast, United Kingdom of Great Britain and Nor
  • McArt DG; Department of Cancer Bioinformatics, Queen's University, Belfast, United Kingdom of Great Britain and Northern Ireland.
  • Roddy A; Department of Cancer Bioinformatics, Queen's University, Belfast, United Kingdom of Great Britain and Northern Ireland.
  • McDermott C; Ovarian Cancer Research Programme, Centre for Cancer Research and Cell Biology, Queen's University, Belfast, United Kingdom of Great Britain and Northern Ireland.
  • Ferris J; Ovarian Cancer Research Programme, Centre for Cancer Research and Cell Biology, Queen's University, Belfast, United Kingdom of Great Britain and Northern Ireland.
  • Buckley NE; Ovarian Cancer Research Programme, Centre for Cancer Research and Cell Biology, Queen's University, Belfast, United Kingdom of Great Britain and Northern Ireland; School of Pharmacy, Queen's University, Belfast, United Kingdom of Great Britain and Northern Ireland.
  • Coulter P; School of Pharmacy, Queen's University, Belfast, United Kingdom of Great Britain and Northern Ireland.
  • McCabe N; Ovarian Cancer Research Programme, Centre for Cancer Research and Cell Biology, Queen's University, Belfast, United Kingdom of Great Britain and Northern Ireland.
  • Eddie SL; Ovarian Cancer Research Programme, Centre for Cancer Research and Cell Biology, Queen's University, Belfast, United Kingdom of Great Britain and Northern Ireland.
  • Dunne PD; Department of Translational Cancer Genomics, Centre for Cancer Research and Cell Biology, Queen's University, Belfast, United Kingdom of Great Britain and Northern Ireland.
  • O'Reilly P; Department of Cancer Bioinformatics, Queen's University, Belfast, United Kingdom of Great Britain and Northern Ireland.
  • Gilmore A; Department of Cancer Bioinformatics, Queen's University, Belfast, United Kingdom of Great Britain and Northern Ireland.
  • Feeney L; Ovarian Cancer Research Programme, Centre for Cancer Research and Cell Biology, Queen's University, Belfast, United Kingdom of Great Britain and Northern Ireland; Northern Ireland Cancer Centre, Belfast Health and Social Care Trust, Belfast, United Kingdom of Great Britain and Northern Ireland.
  • Ewing DL; Ovarian Cancer Research Programme, Centre for Cancer Research and Cell Biology, Queen's University, Belfast, United Kingdom of Great Britain and Northern Ireland.
  • Drapkin RI; Ovarian Cancer Research Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Salto-Tellez M; Ovarian Cancer Research Programme, Centre for Cancer Research and Cell Biology, Queen's University, Belfast, United Kingdom of Great Britain and Northern Ireland; Northern Ireland Molecular Pathology Laboratory, Centre for Cancer Research and Cell Biology, Queens University, Belfast, United Kingdom
  • Kennedy RD; Ovarian Cancer Research Programme, Centre for Cancer Research and Cell Biology, Queen's University, Belfast, United Kingdom of Great Britain and Northern Ireland; Northern Ireland Cancer Centre, Belfast Health and Social Care Trust, Belfast, United Kingdom of Great Britain and Northern Ireland.
  • Harley IJG; Ovarian Cancer Research Programme, Centre for Cancer Research and Cell Biology, Queen's University, Belfast, United Kingdom of Great Britain and Northern Ireland; Northern Ireland Centre for Gynaecological Cancer, Belfast Health and Social Care Trust, Belfast, United Kingdom of Great Britain and Nor
  • McCluggage WG; Ovarian Cancer Research Programme, Centre for Cancer Research and Cell Biology, Queen's University, Belfast, United Kingdom of Great Britain and Northern Ireland; Northern Ireland Centre for Gynaecological Cancer, Belfast Health and Social Care Trust, Belfast, United Kingdom of Great Britain and Nor
  • Mullan PB; Ovarian Cancer Research Programme, Centre for Cancer Research and Cell Biology, Queen's University, Belfast, United Kingdom of Great Britain and Northern Ireland.
Gynecol Oncol ; 155(2): 305-317, 2019 11.
Article en En | MEDLINE | ID: mdl-31493898
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Cistadenocarcinoma Seroso Tipo de estudio: Prognostic_studies Aspecto: Ethics Límite: Female / Humans Idioma: En Revista: Gynecol Oncol Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Cistadenocarcinoma Seroso Tipo de estudio: Prognostic_studies Aspecto: Ethics Límite: Female / Humans Idioma: En Revista: Gynecol Oncol Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos